Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

364 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials.
Petrou P, Gothelf Y, Argov Z, Gotkine M, Levy YS, Kassis I, Vaknin-Dembinsky A, Ben-Hur T, Offen D, Abramsky O, Melamed E, Karussis D. Petrou P, et al. JAMA Neurol. 2016 Mar;73(3):337-44. doi: 10.1001/jamaneurol.2015.4321. JAMA Neurol. 2016. PMID: 26751635 Clinical Trial.
Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis.
Karussis D, Karageorgiou C, Vaknin-Dembinsky A, Gowda-Kurkalli B, Gomori JM, Kassis I, Bulte JW, Petrou P, Ben-Hur T, Abramsky O, Slavin S. Karussis D, et al. Among authors: petrou p. Arch Neurol. 2010 Oct;67(10):1187-94. doi: 10.1001/archneurol.2010.248. Arch Neurol. 2010. PMID: 20937945 Free PMC article. Clinical Trial.
T-cell reactivity against AQP4 in neuromyelitis optica.
Vaknin-Dembinsky A, Brill L, Kassis I, Petrou P, Ovadia H, Ben-Hur T, Abramsky O, Karussis D. Vaknin-Dembinsky A, et al. Among authors: petrou p. Neurology. 2012 Aug 28;79(9):945-6. doi: 10.1212/WNL.0b013e318266fc2b. Epub 2012 Aug 15. Neurology. 2012. PMID: 22895587 No abstract available.
Humoral and Cellular Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients with Multiple Sclerosis: An Israeli Multi-Center Experience Following 3 Vaccine Doses.
Milo R, Staun-Ram E, Karussis D, Karni A, Hellmann MA, Bar-Haim E, Miller A; Israeli Neuroimmunology Study Group on COVID-19 Vaccination in Multiple Sclerosis. Milo R, et al. Front Immunol. 2022 Apr 1;13:868915. doi: 10.3389/fimmu.2022.868915. eCollection 2022. Front Immunol. 2022. PMID: 35432335 Free PMC article.
Vision and Vision-Related Measures in Progressive Multiple Sclerosis.
Backner Y, Petrou P, Glick-Shames H, Raz N, Zimmermann H, Jost R, Scheel M, Paul F, Karussis D, Levin N. Backner Y, et al. Among authors: petrou p. Front Neurol. 2019 May 3;10:455. doi: 10.3389/fneur.2019.00455. eCollection 2019. Front Neurol. 2019. PMID: 31130910 Free PMC article.
364 results